Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Eli Lilly Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab January 31, 2017 Minerva Neurosciences Reports First Quarter 2017 Financial Results And Business Updates May 3, 2017 Stock Falls as FDA Slaps Warning on Researcher Studying Ionis Pharma's IONIS-TTRrx May 10, 2017
Eli Lilly Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab January 31, 2017
